LATITUDE PHARMACEUTICALS INC has a total of 22 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2010. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are TLC BIOPHARMACEUTICALS INC, TAIWAN LIPOSOME CO LTD and ICDPHARMA LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | China | 3 | |
#5 | Canada | 2 | |
#6 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Chen Andrew Xian | 17 |
#2 | Chen Hailiang | 11 |
#3 | Orida Norman Keith | 8 |
#4 | Dang Hau Huu | 3 |
#5 | Okumu Franklin | 3 |
#6 | Chen Andrew | 3 |
#7 | Chen Andrew X | 2 |
#8 | Chen Hailliang | 2 |
#9 | Chu Jan-Jon | 1 |
#10 | Webb Julie Ann | 1 |
Publication | Filing date | Title |
---|---|---|
WO2017040928A1 | Stabilized glucagon solutions | |
AU2016215070A1 | Aqueous solution formulations of vancomycin | |
CN107106659A | parenteral glucagon formulation | |
US2013189316A1 | Nanoemulsion composition containing vitamin K | |
CN102933200A | One-phase gel composition comprising phospholipids | |
WO2011031462A2 | Compositions for delivery of insoluble agents |